Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

SINOPHARM MODERN (600420.SS)

Compare
10.20
+0.02
+(0.20%)
At close: 3:00:01 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,937,525.11
10,937,525.11
12,069,930.21
12,959,320.53
13,944,948.27
Cost of Revenue
6,645,214.33
6,645,214.33
7,444,013.14
8,024,562.53
7,848,140.98
Gross Profit
4,292,310.78
4,292,310.78
4,625,917.07
4,934,758.01
6,096,807.29
Operating Expense
2,495,720.25
2,495,720.25
3,554,340.04
3,986,876.98
4,874,728.82
Operating Income
1,796,590.54
1,796,590.54
1,071,577.03
947,881.02
1,222,078.46
Net Non Operating Interest Income Expense
88,679.89
88,679.89
47,052.85
-52,191.69
-67,373
Pretax Income
1,673,053.84
1,673,053.84
1,096,559.56
984,119.88
918,208.78
Tax Provision
340,974.13
340,974.13
131,948.83
116,634.90
97,062.93
Net Income Common Stockholders
1,083,622.88
1,083,622.88
691,880.50
627,794.83
568,280.77
Basic EPS
0.81
--
0.54
0.61
0.55
Diluted EPS
0.81
--
0.54
0.54
0.48
Basic Average Shares
1,341,117.43
--
1,273,477.81
1,026,983.20
1,026,889.72
Diluted Average Shares
1,341,117.43
--
1,273,477.81
1,156,372.87
1,177,783.98
Total Operating Income as Reported
1,751,923.51
1,751,923.51
1,081,627.09
966,135.11
897,562.05
Rent Expense Supplemental
3,469.27
3,469.27
7,952.67
5,565.60
19,332.75
Total Expenses
9,140,934.58
9,140,934.58
10,998,353.19
12,011,439.51
12,722,869.81
Net Income from Continuing & Discontinued Operation
1,083,622.88
1,083,622.88
691,880.50
627,794.83
568,280.77
Normalized Income
1,241,138.87
1,241,138.87
773,767.44
654,285.62
763,667.35
Interest Income
86,969.89
86,969.89
109,024.76
59,345.99
48,842.43
Interest Expense
36,887.58
36,887.58
57,883.69
107,310.33
110,465.50
Net Interest Income
88,679.89
88,679.89
47,052.85
-52,191.69
-67,373
EBIT
1,709,941.41
1,709,941.41
1,154,443.25
1,091,430.21
1,028,674.28
EBITDA
2,482,259.49
2,482,259.49
1,973,328.93
1,933,918.71
1,848,941.97
Reconciled Cost of Revenue
6,645,214.33
6,645,214.33
7,444,013.14
8,024,562.53
7,848,140.98
Reconciled Depreciation
772,318.08
772,318.08
818,885.68
842,488.50
820,267.69
Net Income from Continuing Operation Net Minority Interest
1,083,622.88
1,083,622.88
691,880.50
627,794.83
568,280.77
Total Unusual Items Excluding Goodwill
-197,835.55
-197,835.55
-93,088.24
-30,052.53
-218,482.10
Total Unusual Items
-197,835.55
-197,835.55
-93,088.24
-30,052.53
-218,482.10
Normalized EBITDA
2,680,095.05
2,680,095.05
2,066,417.17
1,963,971.24
2,067,424.08
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-40,319.57
-40,319.57
-11,201.29
-3,561.73
-23,095.52
12/31/2021 - 6/16/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade